Stockscreener 앱 받기
3.88
0.89%
-0.04
전일 마감가:
$3.92
열려 있는:
$3.92
하루 거래량:
433.62K
Relative Volume:
0.48
시가총액:
$256.89M
수익:
$69.23M
순이익/손실:
$-33.10M
주가수익비율:
-3.2881
EPS:
-1.18
순현금흐름:
$-39.26M
1주 성능:
-14.52%
1개월 성능:
+8.82%
6개월 성능:
-2.26%
1년 성능:
+421.48%
1일 변동 폭
$3.87
$4.00
1주일 범위
$3.87
$4.55
52주 변동 폭
$0.52
$5.92
Neuronetics Inc Stock (STIM) Company Profile
명칭
Neuronetics Inc
전화
877-600-7555
주소
3222 PHOENIXVILLE PIKE, MALVERN, PA
STIM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
3.885 | 273.10M | 69.23M | -33.10M | -39.26M | -1.18 |
|
ABT
Abbott Laboratories
|
130.16 | 233.71B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
102.39 | 152.83B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
376.96 | 144.35B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.18 | 119.00B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.16 | 46.00B | 5.69B | 4.14B | 577.90M | 6.96 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2021-10-13 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | 개시 | BTIG Research | Buy |
| 2018-07-24 | 개시 | Canaccord Genuity | Buy |
모두보기
Neuronetics Inc 주식(STIM)의 최신 뉴스
How does Neuronetics Inc. compare to its peersFastest Growing Stock Radar - mustnews.co.kr
Neuronetics Study Shows Strong Antidepressant Results for Teens and Young Adults Using NeuroStar TMS - MSN
Can Neuronetics Inc. expand into new markets3x Potential Swing Trade Ideas - mustnews.co.kr
Neuronetics Issues Inducement Equity Awards to New Hires - MSN
Neuronetics shares fall 3.42% intraday after granting inducement awards to new employees. - AInvest
Here's What Analysts Are Forecasting For Neuronetics, Inc. (NASDAQ:STIM) After Its Second-Quarter Results - simplywall.st
Neuronetics announces inducement grant - Medical Buyer
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Neuronetics Expands Leadership Team with 31,650 RSU Grants: Major Push in Neurohealth Tech - Stock Titan
Neuronetics: Canaccord Genuity maintains Buy, PT down to $7 from $8. - AInvest
Neuronetics adjusts 2025 gross margin guidance to 48%-50% as Greenbrook revenue mix rises - MSN
Neuronetics Takes A Leap In Mental Health Tech - Finimize
Neuronetics, Inc. (NASDAQ:STIM) Q2 2025 Earnings Call Transcript - Insider Monkey
Canaccord Genuity lowers Neuronetics stock price target on margin concerns By Investing.com - Investing.com Canada
Canaccord Genuity lowers Neuronetics stock price target on margin concerns - Investing.com
Neuronetics (STIM) Price Target Reduced by Canaccord Analyst - GuruFocus
Neuronetics Reports Q2 2025 Financial Results Surge - The Globe and Mail
Neuronetics: Q2 Earnings Snapshot - Greenwich Time
Neuronetics Inc (STIM) Q2 2025 Earnings Call Highlights: Record Revenue Growth Amid Strategic Shifts - GuruFocus
Neuronetics Inc (STIM) Q2 2025 Earnings Call Highlights: Record Revenue Growth Amid Strategic Shifts By GuruFocus - Investing.com Canada
Neuronetics 2025 Q2 Earnings Beats Expectations as Net Loss Narrows 54.5% - AInvest
Neuronetics Reports Revenue Growth Amid Greenbrook Acquisition - TipRanks
Neuronetics’ Earnings Call: Revenue Growth Amid Challenges - TipRanks
Neuronetics' 2025 Gross Margin Guidance: A Calculated Path to Profitability Amid Integration Challenges - AInvest
Neuronetics Q2 2025: Navigating Contradictions in Marketing Strategies and Revenue Expectations - AInvest
Earnings call transcript: Neuronetics Q2 2025 Misses EPS Forecast, Stock Drops - Investing.com
Neuronetics Q3 Revenue Forecast $37M-$39M, Close to Consensus Estimate of $38.22M - AInvest
Neuronetics 2025 Financial Forecast: Revenue Ranges from $149M to $155M, Gross Margin at 48%-50% - AInvest
Neuronetics Q3 Revenue Outlook: $37M-$39M vs. Consensus $38.22M - AInvest
Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance
Neuronetics Reports Second Quarter 2025 Financial and Operating Results | STIM Stock News - GuruFocus
Neuronetics Q2 2025 slides reveal strong revenue growth, path to profitability - Investing.com
Neuronetics Q2 Financial Results: $10.1 Million Loss ReportedNews and Statistics - IndexBox
Neuronetics earnings missed by $0.07, revenue topped estimates - Investing.com
Neuronetics' Q2 2025 Earnings: A Tale of Two Metrics – Revenue Growth vs. Persistent Losses - AInvest
Neuronetics, Inc. SEC 10-Q Report - TradingView
Neuronetics Reports Second Quarter 2025 Financial and Operating Results - The Globe and Mail
Healthcare firm Neuronetics Q2 revenue misses estimates - MarketScreener
Neuronetics Q2 revenue up 18% YoY to $38.1 mln. - AInvest
Neuronetics to Present at the Canaccord Genuity 45th Annual Grow - GuruFocus
Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference - The Manila Times
Neuronetics, Inc. CEO Keith Sullivan to Present at Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 - Quiver Quantitative
Neuronetics CEO Showcases Neurohealth Innovation at Major Growth Conference - Stock Titan
What To Expect From Neuronetics Inc (STIM) Q2 2025 Earnings - Yahoo Finance
Is Neuronetics Inc. stock overvalued or undervaluedHigh-profit stock alerts - Jammu Links News
What is the risk reward ratio of investing in Neuronetics Inc. stockInvest confidently with actionable market data - Jammu Links News
When is Neuronetics Inc. stock expected to show significant growthGrow your portfolio with growth-oriented stocks - Jammu Links News
How many analysts rate Neuronetics Inc. as a “Buy”Capitalize on high-yield stocks early - Jammu Links News
What analysts say about Neuronetics Inc. stockConsistent high-yield stocks - Jammu Links News
How strong is Neuronetics Inc. company’s balance sheetNavigate the market with precision tools - Jammu Links News
What are analysts’ price targets for Neuronetics Inc. in the next 12 monthsUnprecedented growth rates - Jammu Links News
Neuronetics Inc (STIM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.30%
1.23%
자본화:
|
볼륨(24시간):